Navigation Links
QuantaLife™ Kicks Off Droplet Digital™ PCR Road Show
Date:8/26/2011

PLEASANTON, Calif., Aug. 26, 2011 /PRNewswire/ -- QuantaLife, Inc., a pioneer in the area of digital PCR, is embarking on a seven-city tour to give scientists the opportunity to evaluate the capabilities of digital PCR and see the QuantaLife Droplet Digital PCR (ddPCR™) System in action. The tour will start on Monday, September 12 in Boston and finish up in San Francisco on Friday, September 23.

The QuantaLife ddPCR System claims to be the world's most precise quantitative PCR system. It introduces the next generation of PCR by providing absolute quantification of targeted nucleic acid molecules, a capability that could play a significant role in the development of companion diagnostics and the emergence of personalized medicine – a role that has long been held by real-time PCR.

The Droplet Digital PCR Road Show will take place at the following cities from September 12 through September 23:

  • Boston, MA: Monday, September 12
  • Potomac, MD: Tuesday, September 13
  • New York, NY: Friday, September 16
  • Chicago, IL: Monday, September 19
  • Seattle, WA: Tuesday, September 20
  • San Diego, CA: Wednesday, September 21
  • San Francisco, CA: Friday, September 23

The featured speaker is Dr. Jason H. Bielas of the Fred Hutchinson Cancer Research Center who will present his results from the use of the ddPCR system in the study of mutation detection in clinical samples. Breakout sessions will also be held on the use of ddPCR for sensitive detection of rare mutants, measurement of copy number, and gene expression.  A ddPCR system will be available for demonstration.

There is no charge for attendees. Details and registration information are available at www.QuantaLife.com or by calling (650) 823-6366. Space is limited, and early registration is strongly encouraged.

The QuantaLife Droplet Digital PCR system was introduced last November at the 60th Annual American Society of Human Genetics Meeting and was recognized recently with the 2011 North American Frost & Sullivan Award for New Product Innovation.

About QuantaLife

QuantaLife has developed the 3rd generation of PCR technology that quantifies DNA molecules by Droplet Digital™ PCR. Droplet Digital PCR provides an absolute measure of target molecules with unrivaled sensitivity and precision.  The company's mission is to provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.


'/>"/>
SOURCE QuantaLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BIOSCIENCE EAST, the Life Sciences Industry Map, Highlighting Global Leaders in Healthcare Innovation, Kicks Off 5th Edition
2. CarePoint Partners Kicks Off Food Drive to Help Fight Hunger in Twenty-One Local Communities
3. National Anesthesia Services Kicks Off 2010 Operation Iraq: The Spirit of Christmas Campaign With $10,000 Donation
4. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
5. The AccuLift Phenomenon Kicks off on CBS The Early Show
6. ASPEX Kicks Off Free Send Us Your Sample Microscopy Campaign
7. American Lung Association of the Mid-Atlantic Kicks Off 2009-2010 Faces of Influenza Campaign in Philadelphia
8. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
9. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
10. QuantaLife, Inc. Receives Tax Credit for Development of Droplet Digital™ PCR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
(Date:3/28/2017)... BOSTON , March 28, 2017  Market ... today announced a partnership with premium news content ... pharmaceutical companies to extract key insights from Dow ... mining technology. The Linguamatics I2E platform ... 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul ... , WHAT: , Medical doctors and PhD scientists will speak to the press on ... Trump in support of an independent vaccine safety commission. , WHERE: , Zenger ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management Association (RBMA) ... as its new executive director. Mr. Still was selected through a careful months-long search ... as he is known to our members, has been a part of building the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... physicians, Paul Yost, will begin serving as new board chair for Orange County ... Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... MA (PRWEB) , ... March 28, 2017 , ... ... for direct measurement of corrosive ions found in power plant water and steam. ... components such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. ...
Breaking Medicine News(10 mins):